[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:early-t-precursor-acute-lymphoblastic-leukemia":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Early T Precursor Acute Lymphoblastic Leukemia",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT03826992","Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia",[11],"Phase 1","RECRUITING","2026-08-26T02:18:53.782384Z","2026-05-05T02:43:29.669276Z",[],[]]